Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced ...

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.